Boulder, United States
Front Range Biosciences, founded in 2015 and headquartered in the United States, is dedicated to revolutionizing agriculture through cutting-edge biotechnologies. The company's slogan, "We’re growing more than the world’s next crop. We’re growing a better future," captures its mission to enhance profitability and safety in agriculture while spurring innovation.
Specializing in innovative practices such as tissue culturing and genetic assays, Front Range Biosciences is uniquely positioned to tackle three pivotal challenges faced by plant growers: high expenses, risks, and a stagnation in innovation. Their vertically integrated model ensures seamless execution from development to market, supported by a robust IP portfolio and strategic licensing.
In August 2020, the company secured a Series B investment from KEY Investment Partners, underscoring investor confidence in their approach. With an interdisciplinary team of experts, including PhD bioscientists and MIT MBAs, the company is well-equipped to pioneer the future of modern plant breeding and growing.
